Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Enterprise value to EBITDA ratio
Latest
0.89
↑ 155% vs avg
Percentile
P86
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-1.62
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.89 | +175.4% |
| 2023 | -1.18 | +73.7% |
| 2022 | -4.51 | -137.5% |
| 2021 | -1.90 | -30.2% |
| 2020 | -1.46 | -27.1% |
| 2019 | -1.15 | +1.2% |
| 2018 | -1.16 | -16.0% |
| 2017 | -1.00 | -22.6% |
| 2016 | -0.82 | +79.3% |
| 2015 | -3.95 | - |